3 - 9 March 2018
These are links to news stories from the last week that may be of interest to people in the UK. The link beneath each item will take you to the original story.
Please note that the MS Trust did not write the original items and does not endorse their content nor any claims made in them.
To keep up to date on all the latest news, views and research on multiple sclerosis, sign up for Open Door, our free newsletter or regular email alerts
Zinbryta withdrawn due to safety fears
The makers of Zinbryta (daclizumab), a disease modifying drug for relapsing MS, have withdrawn the medication due to cases of serious brain inflammation (encephalitis). No new research is planned.
MS Trust link: Zinbryta (daclizumab)
Sunshine exposure reduces MS risk
Canadian research has found that growing up and spending time outdoors in a sunnier climate with exposure to UV-B light led to a reduction in risk of developing MS. A smaller proportion of people with MS grew up in sunnier areas than in a less sunny climate.
MS Trust link: Vitamin D